BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 14508202)

  • 1. Prediction of cardiac death in hypertensive patients with suspected or known coronary artery disease by stress technetium-99m tetrofosmin myocardial perfusion imaging.
    Elhendy A; Schinkel AF; Van Domburg RT; Bax JJ; Poldermans D
    J Hypertens; 2003 Oct; 21(10):1945-51. PubMed ID: 14508202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incremental value of exercise technetium-99m tetrofosmin myocardial perfusion single-photon emission computed tomography for the prediction of cardiac events.
    Schinkel AF; Elhendy A; van Domburg RT; Bax JJ; Vourvouri EC; Bountioukos M; Rizzello V; Agricola E; Valkema R; Roelandt JR; Poldermans D
    Am J Cardiol; 2003 Feb; 91(4):408-11. PubMed ID: 12586253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of dobutamine-atropine stress (99m)Tc-tetrofosmin myocardial perfusion SPECT in patients with known or suspected coronary artery disease.
    Schinkel AF; Elhendy A; van Domburg RT; Bax JJ; Roelandt JR; Poldermans D
    J Nucl Med; 2002 Jun; 43(6):767-72. PubMed ID: 12050321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic stratification using dobutamine stress 99mTc-tetrofosmin myocardial perfusion SPECT in elderly patients unable to perform exercise testing.
    Schinkel AF; Elhendy A; Biagini E; van Domburg RT; Valkema R; Rizello V; Pedone C; Simoons M; Bax JJ; Poldermans D
    J Nucl Med; 2005 Jan; 46(1):12-8. PubMed ID: 15632027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk stratification of patients after myocardial revascularization by stress Tc-99m tetrofosmin myocardial perfusion tomography.
    Elhendy A; Schinkel AF; van Domburg RT; Bax JJ; Valkema R; Poldermans D
    J Nucl Cardiol; 2003; 10(6):615-22. PubMed ID: 14668773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term prognostic value of exercise technetium-99m tetrofosmin myocardial perfusion single-photon emission computed tomography.
    Boiten HJ; van der Sijde JN; Ruitinga PR; Valkema R; Geleijnse ML; Sijbrands EJ; van Domburg RT; Schinkel AF
    J Nucl Cardiol; 2012 Oct; 19(5):907-13. PubMed ID: 22875719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eleven-year prognostic value of dobutamine stress (99m)Tc-sestamibi myocardial perfusion imaging in patients with limited exercise capacity.
    Boiten HJ; van Domburg RT; Valkema R; Schinkel AF
    Am J Cardiol; 2015 Apr; 115(7):884-9. PubMed ID: 25661571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of stress Tc-99m tetrofosmin SPECT in patients with previous myocardial infarction: impact of scintigraphic extent of coronary artery disease.
    Elhendy A; Schinkel AF; van Domburg RT; Bax JJ; Valkema R; Poldermans D
    J Nucl Cardiol; 2004; 11(6):704-9. PubMed ID: 15592194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic implications of a normal stress technetium-99m-tetrofosmin myocardial perfusion study in patients with a healed myocardial infarct and/or previous coronary revascularization.
    Schinkel AF; Elhendy A; Bax JJ; van Domburg RT; Huurman A; Valkema R; Biagini E; Rizzello V; Feringa HH; Krenning EP; Simoons ML; Poldermans D
    Am J Cardiol; 2006 Jan; 97(1):1-6. PubMed ID: 16377272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of mortality in heart transplant recipients by stress technetium-99m tetrofosmin myocardial perfusion imaging.
    Elhendy A; van Domburg RT; Vantrimpont P; Poldermans D; Bax JJ; van Gelder T; Baan CC; Schinkel A; Roelandt JR; Balk AH
    Am J Cardiol; 2002 Apr; 89(8):964-8. PubMed ID: 11950436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of 14-year cardiovascular outcomes by dobutamine stress
    Roest S; Boiten HJ; van Domburg RT; Valkema R; Schinkel AFL
    J Nucl Cardiol; 2018 Feb; 25(1):63-71. PubMed ID: 27381341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of fixed perfusion abnormalities on stress technetium-99m sestamibi single-photon emission computed tomography in patients without known coronary artery disease.
    Elhendy A; Schinkel AF; van Domburg RT; Bax JJ; Poldermans D
    Am J Cardiol; 2003 Nov; 92(10):1165-70. PubMed ID: 14609590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic implications of stress Tc-99m tetrofosmin myocardial perfusion imaging in patients with left ventricular hypertrophy.
    Elhendy A; Schinkel AF; van Domburg RT; Bax JJ; Feringa HH; Noordzij PG; Schouten O; Poldermans D
    J Nucl Cardiol; 2007 Jul; 14(4):550-4. PubMed ID: 17679064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-invasive diagnosis of in stent stenosis by stress 99m technetium tetrofosmin myocardial perfusion imaging.
    Elhendy A; Schinkel AF; van Domberg RT; Bax JJ; Valkema R; Poldermans D
    Int J Cardiovasc Imaging; 2006 Oct; 22(5):657-62. PubMed ID: 16628382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of exercise stress technetium-99m-tetrofosmin myocardial perfusion imaging in patients with normal baseline electrocardiograms.
    Elhendy A; Schinkel AF; van Domburg RT; Bax JJ; Valkema R; Huurman A; Feringa HH; Poldermans D
    Am J Cardiol; 2006 Sep; 98(5):585-90. PubMed ID: 16923441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk stratification of patients with angina pectoris by stress 99mTc-tetrofosmin myocardial perfusion imaging.
    Elhendy A; Schinkel AF; van Domburg RT; Bax JJ; Valkema R; Huurman A; Feringa HH; Poldermans D
    J Nucl Med; 2005 Dec; 46(12):2003-8. PubMed ID: 16330563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incremental prognostic value of technetium-99m-tetrofosmin exercise myocardial perfusion imaging for predicting outcomes in patients with suspected or known coronary artery disease.
    Galassi AR; Azzarelli S; Tomaselli A; Giosofatto R; Ragusa A; Musumeci S; Tamburino C; Giuffrida G
    Am J Cardiol; 2001 Jul; 88(2):101-6. PubMed ID: 11448403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of long-term (> 10 year) cardiovascular outcomes in heart transplant recipients: Value of stress technetium-99m tetrofosmin myocardial perfusion imaging.
    Veenis JF; Boiten HJ; van den Berge JC; Caliskan K; Maat APWM; Valkema R; Constantinescu AA; Manintveld OC; Zijlstra F; van Domburg RT; Schinkel AFL
    J Nucl Cardiol; 2019 Jun; 26(3):845-852. PubMed ID: 29116562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is the value of stress (99m)Tc-tetrofosmin myocardial perfusion imaging for the assessment of very long-term outcome in obese patients?
    Korbee RS; Boiten HJ; Ottenhof M; Valkema R; van Domburg RT; Schinkel AF
    J Nucl Cardiol; 2013 Apr; 20(2):227-33. PubMed ID: 23188629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic stratification of obese patients by stress 99mTc-tetrofosmin myocardial perfusion imaging.
    Elhendy A; Schinkel AF; van Domburg RT; Bax JJ; Valkema R; Biagini E; Poldermans D
    J Nucl Med; 2006 Aug; 47(8):1302-6. PubMed ID: 16883009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.